04.22.24 -- Tackling 3 Challenges In Developing An Inhaled Gene Therapy

Regulators in North America and Europe are requiring stricter standards for the manufacture and safety testing for combination products in both the Pharma and med device industries. This two-day summit features expert insight into CP product development, and the complex quality, safety, and regulatory compliance issues facing the CP market. Pharma Ed’s Combination Products Summit 2024 provides comprehensive coverage of current and future trends in combination product development for drugs, biologics and medical devices.

Inhalers hold great potential for delivery of high concentrations of gene therapy directly into the lung. This article shares the experiences of a team who has worked on the development of a gene therapy to treat cystic fibrosis.